Indian biotech CrisprBits closed a US$3 million pre‑Series A round led by Spectrum Impact, the family office of Rajendra Gogri, to expand CRISPR‑based diagnostics and R&D capabilities. The funding will support product development, regulatory work and scaling of laboratory infrastructure for nucleic‑acid detection platforms and gene‑editing tools. CrisprBits’ raise underlines growing investor interest in decentralized CRISPR diagnostics and the commercialization of gene‑editing enabling technologies in emerging biotech markets.